Litcius/Paper detail

The derived neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T‐cell lymphoma

Huangming Hong, Xiaojie Fang, He Huang, Zhao Wang, Tongyu Lin, Herui Yao

2020British Journal of Haematology19 citationsDOIOpen Access PDF

Abstract

To determine whether inflammatory markers, derived neutrophil-to-lymphocyte ratio (dNLR), haemoglobin/platelet ratio (HPR) or platelet/lymphocyte ratio (PLR) are predictive for prognosis in angioimmunoblastic T-cell lymphoma (AITL), we derived dNLR, HPR and PLR values for 110 AITL patients and appropriate cut-off point values to define overall survival (OS) and progression-free survival (PFS). dNLR ≥ 2·2, HPR ≥ 0·4 or PLR < 100 were significant factors for shorter OS and PFS. On univariate analysis, these three parameters were significantly associated with worse OS and PFS. On multivariate analysis, only dNLR remained a significant, independent prognostic factor for both OS and PFS.

Topics & Concepts

Angioimmunoblastic T-cell lymphomaInternal medicineMultivariate analysisNeutrophil to lymphocyte ratioUnivariate analysisMedicineLymphomaLymphocyteUnivariateGastroenterologyTrimethylgalliumOncologyImmunologyMultivariate statisticsT cellChemistryImmune systemEpitaxyLayer (electronics)Metalorganic vapour phase epitaxyMathematicsStatisticsOrganic chemistryLymphoma Diagnosis and TreatmentViral-associated cancers and disordersInflammatory Biomarkers in Disease Prognosis
The derived neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T‐cell lymphoma | Litcius